Related Experiment Video

Updated: Jul 11, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

[Protocol for clinical monitoring of juvenile idiopathic arthritis]

Helena Canhão1, João Eurico Fonseca, Maria José Santos

  • 1Serviço de Reumatologia, Hospital de Santa Maria, Lisbon. helenacanhao@netcabo.pt

Acta Reumatologica Portuguesa
|October 12, 2007
PubMed

Insights

This protocol provides a standardized tool for monitoring juvenile arthritis patients, aiding rheumatologists and pediatricians in evaluating disease activity and treatment response. It aims to improve patient care through consistent assessment methods.

Area of Science:

  • Rheumatology
  • Pediatrics
  • Clinical Assessment

Context:

  • Inflammatory rheumatic diseases require objective monitoring.
  • Newer therapies necessitate validated evaluation tools.
  • Juvenile idiopathic arthritis (JIA) management benefits from standardized follow-up.

Purpose:

  • To introduce the Protocol for Monitoring of Juvenile Arthritis (PMAIJ) as a tool for pediatric rheumatologists and pediatricians.
  • To facilitate the evaluation of disease activity, functional capacity, and treatment response in juvenile arthritis patients.
  • To standardize follow-up procedures across Paediatric Rheumatology Centres.

Summary:

  • The PMAIJ protocol consists of a two-page assessment form.
  • The first page is completed during the initial patient evaluation.
  • The second page is used for initial and all subsequent follow-up appointments.

Impact:

  • Enhances the standardization of juvenile arthritis patient care.
  • Provides valuable data on the clinical evolution of JIA patients.
  • Supports evidence-based decision-making in pediatric rheumatology.

Related Concept Videos

Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...